Monthly Archives: August 2018
The Modern Mobile Workforce: Three ways VUMC is managing risk while respecting your privacy
We all want the convenience of accessing VUMC technology resources (email, calendars, eStar, and other mobile applications) on our personal mobile devices but acknowledge that this convenience comes with risks which must be addressed. (part 4 of 4 from… Continue reading
How and When to Consider Genetic Testing for Colon Cancer?
An unusual case of bloody diarrhea in a young male
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
T-cell exhaustion, or an impaired capacity to secrete cytokines and proliferate with overexpression of immune checkpoint receptors, occurs during chronic viral infections but has also been observed in tumors, including hepatocellular carcinomas (HCCs)…. Continue reading
Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis – Results From the Nurses’ Health Study
Microscopic colitis is a chronic inflammatory disorder of the colon primarily affecting postmenopausal women. However, the relationship between hormonal determinants, including reproductive and menopausal factors, and risk of microscopic colitis has ye… Continue reading
FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
Intestinal bacteria can modify the composition of bile acids and bile acids, which are regulated by the farnesoid X receptor (FXR), affect the survival and growth of gut bacteria. We studied the effects of obeticholic acid (OCA), a bile acid analog and… Continue reading
Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis
There is debate over the effects of long-term oral fluoroquinolone therapy in patients with advanced cirrhosis. We performed a randomized controlled trial to evaluate the effects of long-term treatment with the fluoroquinolone norfloxacin on survival o… Continue reading
Risk of Hepatocellular Cancer in Patients with Non-alcoholic Fatty Liver Disease
There are limited data on the risk of hepatocellular cancer (HCC) in patients with non-alcoholic fatty liver disease (NAFLD). We aimed to estimate the risk of incident HCC among patients with NAFLD. Continue reading
TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes
Hepatitis C virus (HCV) co-opts the very low-density lipoprotein (VLDL) pathway for morphogenesis, maturation, and secretion, and circulates as lipoviroparticles (LVPs). We investigated the functions and underlying mechanisms of the lipid-associated tr… Continue reading
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis
Several secretagogues have been approved treatment of irritable bowel syndrome with constipation (IBS-C). However, their relative efficacy is unclear because there have been no head-to-head randomized controlled trials. We conducted a network meta-anal… Continue reading